Reported 7 months ago
On June 13, 2024, the US Federal Supreme Court unanimously rejected a lawsuit from the anti-abortion camp against the Food and Drug Administration (FDA) for allowing the use of the abortion pill Mifepristone. The justices stated that the lawsuit lacked grounds under the US Constitution, as the plaintiffs failed to prove harm caused by FDA's relaxed regulations. Despite the ruling being seen as good news by abortion rights advocates, the fight is not over, as the case will be sent back to a lower court that previously approved intervention in FDA drug approvals. This marks the first major abortion rights lawsuit accepted by the Supreme Court since the 2022 Anderson v. Wade case, with CNN describing the outcome as a significant blow to the anti-abortion camp. The FDA approved the abortion pill in 2000 and made it more accessible in 2016, with about 60% of abortion cases in the US involving the pill. Critics of the decision vow to continue the fight, arguing that chemical abortion is dangerous and FDA regulations need to be revised for women's safety.
Source: YAHOO